(February 13, 2024, 12:19 PM EST) -- ALEXANDRIA, Va. — In a new petition filed with the Patent Trial and Appeal Board, Dexcom Inc. says that two new claims of the same patent already the subject of inter partes review (IPR) should also be examined after patent owner Abbott Diabetes Care Inc. recently added allegations of their infringement in federal court....